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Abstract
Background: Smoking, obesity and alcohol abuse greatly affect mortality and exhibit a dis-
tinct time dynamic, with their prevalence and associated mortality rates increasing and
(eventually) declining over time. Their combined impact on secular trends in life expectancy
is unknown but is relevant for understanding these trends. We therefore estimate the com-
bined impact of smoking, obesity and alcohol on life-expectancy trends in Europe.
Methods: We used estimated national age-specific smoking-, obesity- and alcohol-
attributable mortality fractions for 30 European countries by sex, 1990–2014, which we
aggregated multiplicatively to obtain lifestyle-attributable mortality. We estimated poten-
tial gains in life expectancy by eliminating lifestyle-attributable mortality and compared
past trends in life expectancy at birth (e0) with and without lifestyle-attributable mortality.
We examined all countries combined, by region and individually.
Results: Among men, the combined impact of smoking, obesity and alcohol on e0
declined from 6.6 years in 1990 to 5.8 years in 2014, mainly due to declining smoking-
attributable mortality. Among women, the combined impact increased from 1.9 to
2.3 years due to mortality increases in all three lifestyle-related factors. The observed
increase in e0 over the 1990–2014 period was 5.0 years for men and 4.0 years for women.
After excluding lifestyle-attributable mortality, this increase would have been 4.2–
4.3 years for both men and women.
Conclusion: Without the combined impact of smoking, obesity and alcohol, the increase
over time in life expectancy at birth would have been smaller among men but larger
among women, resulting in a stable increase in e0, parallel for men and women.
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Introduction
Smoking, alcohol abuse and behavioural factors resulting
in overweight and obesity (unhealthy diets and insufficient
physical activity) are important contributors to non-
communicable-disease mortality.1 Smoking, alcohol and
obesity are considered to be three key preventable risk factors
and public-health problems in Europe,2,3 with a high impact
on mortality and life expectancy.4–14 However, the contribu-
tions of smoking, obesity and alcohol are not constant over
time, because these lifestyle factors tend to evolve as wave-
shaped lifestyle ‘epidemics’ characterized by an initial unprec-
edented increase followed (eventually) by a decline.15–20
Given important (recent) stagnations in increases in life ex-
pectancy in Europe over time,21–25 it is important to assess
how these lifestyle factors influenced secular trends in life ex-
pectancy in different European countries.
Previous research clearly revealed the time-varying nature
of smoking-, obesity- and alcohol-attributable mortality. Past
trends in smoking-attributable mortality show a clear wave
pattern of increases followed by declines that occurred ap-
proximately 30–40 years later than a similar wave pattern for
smoking prevalence.15 This wave pattern has been observed
among men in all European countries, whereas smoking-
attributable mortality appears to still be increasing among
women in the majority of European countries.16 The tripling
of obesity prevalence in Europe since 198026 has resulted in
clear increases in obesity-attributable mortality fractions over
the 1975–2016 period,27 albeit with a recent slowing-down
of the rates of increase.28 Alcohol prevalence and,
subsequently, alcohol-attributable mortality levels, which are
especially high among Eastern-European men,29,30 had been
mostly increasing in Eastern and North-western Europe, al-
though recently they have been stagnating or declining in
most of these countries. In most South-western-European
countries, these levels have been steadily declining, albeit
more slowly in recent years.19,20
Also, various Global Burden of Disease studies esti-
mated trends in risk-attributable deaths and Disability
Adjusted Life Years for different (groups of) risks (behav-
ioural, environmental, occupational, metabolic) from 1990
onwards.31–34 We will complement this work by estimat-
ing the effects of lifestyle-attributable mortality on secular
trends in life expectancy.
Previous studies on the impact of smoking-, obesity-
and alcohol-attributable mortality on trends in life expec-
tancy mostly examined the impact for a single lifestyle fac-
tor and usually for only a selection of
countries.22,23,27,30,35–37 They found that smoking played
an important role in the stagnation of life-expectancy
increases among men in many North-western European
countries in the 1950s and 1960s, and in other European
countries and among women in more recent deca-
des.22,23,35 For obesity, an increasingly large effect on
life-expectancy levels over recent decades was ob-
served.27 A similar trend was found for alcohol in
Finland.36 In addition, the dissimilar trends in alcohol
prevalence between Eastern and non-Eastern Europe
have greatly contributed to diverging (1990–2005) and
converging (2005 onwards) life-expectancy levels across
Europe.30 Although these previous results suggest that
the combined effect of smoking, obesity and alcohol on
life-expectancy trends could be large, this combined ef-
fect has not yet been studied.
Our objective is, therefore, to estimate, for the first
time, the combined impact of smoking, obesity
(BMI 30 kg/m2) and alcohol abuse on trends in life ex-
pectancy for men and women in Europe and to determine
how trends in life expectancy would look like without this
combined impact. We study the majority of European
countries (N¼ 30) combined, with additional attention on
differences by region (North, West, South, Central, East)
and country.
Key Messages
• We observed a large combined impact of smoking, obesity, and alcohol on trends in life expectancy at birth (e0) in
Europe. Without its impact, the increase over time in e0 would have been smaller among men but larger among
women.
• We identified a stable increase in life expectancy for non-lifestyle-attributable mortality, which occurred in parallel for
men and women in most European countries, and was, for men, more similar between countries than for the
observed life-expectancy trends.
• Distinguishing between non-lifestyle-attributable mortality and lifestyle-attributable mortality is important to better
understand current trends in life expectancy and to predict future trends.
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Data and methods
For the 30 countries under study, we used previously calcu-
lated estimates of smoking-, obesity- and alcohol-
attributable mortality fractions by sex and single adult
ages (smoking: 35–100 years; obesity and alcohol: 20–
100 years) (see next paragraph).16,20,38 In addition, we
used age-, sex-, country- and year-specific all-cause mortal-
ity and population data from the Human Mortality
Database.39 We studied the period 1990–2014 because
alcohol-attributable mortality could be estimated only since
1990 and smoking-attributable mortality could not be esti-
mated after 2014 for several countries due to the unavailabil-
ity of lung-cancer-mortality rates for more recent years (see
Supplementary Data & Methods—Appendix 1, available as
Supplementary data at IJE online, for the data availability
by country for the different elements).
Smoking-attributable-mortality fractions were indi-
rectly estimated using a simplified version of the com-
monly applied Peto-Lopez methodology.16,40,41 The
method estimates exposure to smoking based on lung-
cancer mortality rates that are adjusted for the part not
due to smoking and applies to this exposure the relative
risks (RRs) of dying from smoking. For obesity-
attributable mortality, the estimates stem from the appli-
cation of the population-attributable fraction formula to
(estimated) prevalence data42 using all-cause RRs of dy-
ing from obesity,43 in line with previous studies, e.g.27.
Alcohol-attributable mortality fractions were estimated
based on alcohol-attributable mortality rates obtained
from the Global Burden of Disease 2017 study,31,44 ad-
justed for ages 65þ using the age pattern for alcohol-
related causes of death.20
To estimate the share of mortality due to smoking, obe-
sity and alcohol combined, we used the multiplicative ag-
gregation of the fractions for the individual risk factors,
using the formula45:




where i stands for the individual risk factor and
PAF1:n stands for the lifestyle-attributable mortality frac-
tion for the three lifestyle factors combined, which we refer
to as the lifestyle-attributable mortality fraction (LAMF).
This aggregation rests on the strong assumption that risk
factors are independent and uncorrelated.45 However, vali-
dation studies have demonstrated that the resulting esti-
mates may closely resemble the true combined effect.31,46
By multiplying the age- and sex-specific smoking-, obe-
sity-, alcohol- and lifestyle-attributable mortality fractions
to the respective all-cause mortality rates, we obtained age-
and sex-specific smoking-, obesity-, alcohol- and lifestyle-
attributable mortality rates. By multiplying the all-cause
mortality rates by one minus the fractions, we obtained the
age- and sex-specific non-smoking-, non-obesity-, non-al-
cohol- and non-lifestyle-attributable mortality rates.
To aid the interpretation of the results from our main
analysis (see below), we performed two initial analyses.
First, we examined the trends over time in the share of
mortality that is attributable to the different lifestyle fac-
tors. We obtained shares across adult ages (20–100 years)
by applying direct standardization to the age-specific frac-
tions using the age composition of deaths for the specific
populations in 2010. Second, we examined the impact on
life expectancy at birth (e0) of the separate and combined
lifestyle factors, and the trends therein over time, by calcu-
lating the potential gain in life expectancy (PGLE)47 if
smoking-, obesity-, alcohol- and lifestyle-attributable mor-
tality were eliminated. The PGLE values are calculated by
comparing the e0 value for all-cause mortality to the e0
value based on life-table calculations applied to non-
smoking-, non-obesity-, non-alcohol- and non-lifestyle-
attributable mortality rates, respectively.
For our main aim of estimating the (combined) impact
of smoking, obesity and alcohol on life-expectancy trends
in Europe, we graphically compared the trends over time
in observed e0 (¼ for all-cause mortality) with the trends in
estimated e0 values (¼ for non-smoking-, non-obesity-,
non-alcohol- and non-lifestyle-attributable mortality) (see
before). To compare the overall change in observed e0
over the 1990–2014 period with this change in estimated
e0 values, we subtracted the respective e0 values in 1990
from the respective e0 values in 2014.
See the Supplementary Data & Methods document,
available as Supplementary data at IJE online, for more
details.
Results
Before describing the results of our main analysis in
Table 2 and Figure 3, we first describe the results of our
background analyses in Figure 1, Table 1 and Figure 2.
Whereas the tables and figures in the manuscript show the
results by European region, the respective supplementary
tables and figures, available as Supplementary data at IJE
online, show the country-specific results.
Across all 30 European countries in 2014, the age-
standardized share of mortality due to smoking, obesity
and alcohol combined (¼ lifestyle-attributable mortality
fraction) was 38% among men and 19% among women.
Among men, the LAMF mostly declined over the 1990–
2014 period, albeit only recently in many Northern
European and Central and Eastern European (CEE)
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countries (Figure 1 and Supplementary Figure 1, available
as Supplementary data at IJE online). Among women, the
LAMF generally increased over time. The declines in the
LAMF for men were mostly driven by declines in smoking-
attributable mortality, which started later in CEE. These
declines in smoking-attributable mortality were, however,
counterbalanced by increases in obesity-attributable mor-
tality and, in Northern and CEE countries, as well by
(decelerating) increases in alcohol-attributable mortality.
The increases in the LAMF for women were driven by
increases in smoking-attributable mortality, in obesity-
attributable mortality and—particularly in CEE—in
alcohol-attributable mortality.
The potential gain in life expectancy (PGLE) by elimi-
nating lifestyle-attributable mortality declined from 6.6 to
5.8 years among men and increased from 1.9 to 2.3 years
Figure 1 Trends over time in age-standardized smoking-, obesity- and alcohol-attributable mortality fractions (separately and combined) (%), ages 20–
100 years, 1990–2014*, for the different European regions, by sex. Lifestyle refers to smoking, obesity and alcohol combined. *For 2011 up to 2014, the
weighted averages were calculated using the data for the latest available year: Bulgaria (2010), Greece (2013), Ukraine (2012) and Russia (2013).
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among women across the 30 European countries over the
1990–2014 period (Table 1 and Figure 2). Among men in
Eastern Europe, the combined impact of smoking, obesity
and alcohol on life expectancy was the greatest and was—
in contrast to other regions—increasing up to 2005 primar-
ily due to the increases in the PGLE for alcohol (Table 1 and
Supplementary Table 1, available as Supplementary data at
IJE online, Figure 2 and Supplementary Figure 2, available as
Supplementary data at IJE online). Among women, the im-
pact was the smallest and hardly changing in Southern
Europe because moderate increases in PGLE for smoking and
obesity were almost offset by small declines in PGLE for
alcohol.
Between 1990 and 2014, e0 increased by 5.0 years
among men across the 30 European countries (Table 2).
Without lifestyle-attributable mortality, this increase
would have been 4.2 years (i.e. 0.8 fewer years). The im-
pact of lifestyle factors on life-expectancy trends was larg-
est among men in Western, Southern and Central Europe,
where the increase in e0 would have been about 1.5 years
lower without lifestyle-attributable mortality (Table 2 and
Supplementary Table 2, available as Supplementary data
at IJE online). By contrast, among Eastern-European men,
excluding lifestyle-attributable mortality would have
resulted in a 0.4-year higher increase in e0. Among
European women, the average increase in e0 from 1990 to
2014 was 4.0 years, whereas it would have been 4.3 years
(i.e. 0.3 years higher) after excluding lifestyle-attributable
mortality (Table 2). An increase in e0 after excluding
lifestyle-attributable mortality can be observed for women
in all European regions and countries (Table 2 and
Supplementary Table 2, available as Supplementary data
at IJE online). This impact of lifestyle factors on life-
expectancy trends was biggest in Central Europe (differ-
ence of 0.7 years) and smallest in Southern Europe (differ-
ence of 0.1 years).
The trend in e0 after excluding lifestyle-attributable mor-
tality was not only very similar for men and women across
the 30 European countries (4.2 and 4.3 years, respectively);
it was also more similar between countries and regions than
all-cause mortality, at least for men (Figure 3). Among men,
the variance between countries in e0 trends after excluding
lifestyle-attributable mortality was 2.3, compared with 4.4
for all-cause mortality (Supplementary Table 2, available as
Supplementary data at IJE online). Among women, the re-
spective variances (2.0 vs 1.8) did not differ much. The in-
crease in e0 was still far less favourable in Eastern Europe
than in the other regions, even after excluding lifestyle-
attributable mortality (Table 2). This seems mainly driven
by the declines in e0 in the early 1990s (Figure 3). From
around 2000, the increases in e0 were more similar between
regions/countries.
Table 1 Impact of smoking, obesity and alcohol (separately and combined) on life expectancy at birth (e0) in 30 European coun-
tries, by sex and region, 1990 and 2014a by means of estimates of the potential gain in life expectancy (PGLE) (in years) from the
elimination of mortality linked to the respective lifestyle factor. Lifestyle refers to smoking, obesity and alcohol combined
PGLE 1990 (in years) PGLE 2014a (in years)
e0 1990 Lifestyle Smoking Obesity Alcohol e0 2014a Lifestyle Smoking Obesity Alcohol
Men
Europe 69.28 6.58 4.85 0.78 1.52 74.26 5.84 3.36 1.34 1.83
Northern Europe 73.11 4.06 2.83 0.66 0.84 79.42 3.04 1.40 1.03 0.83
Western Europe 72.51 5.51 3.98 0.72 1.27 79.02 3.94 2.19 1.18 0.96
Southern Europe 73.40 5.28 3.61 0.69 1.48 79.99 3.78 2.23 1.06 0.83
Central Europe 66.34 7.72 5.89 0.94 1.59 73.86 6.27 3.88 1.47 1.61
Eastern Europe 64.52 7.74 5.87 0.77 1.72 65.72 8.10 4.56 1.43 2.95
Women
Europe 77.28 1.94 0.62 0.99 0.38 81.23 2.30 0.77 1.18 0.45
Northern Europe 79.38 1.86 0.97 0.64 0.32 83.72 2.41 1.40 0.81 0.31
Western Europe 79.16 1.95 0.84 0.74 0.43 83.82 2.38 1.24 0.95 0.32
Southern Europe 80.08 1.47 0.27 0.79 0.45 85.10 1.59 0.52 0.92 0.20
Central Europe 75.07 2.10 0.86 1.03 0.28 81.08 2.81 1.53 1.14 0.31
Eastern Europe 74.57 2.04 0.47 1.27 0.35 76.44 2.31 0.23 1.44 0.72
aFor 2014, the weighted averages were calculated using the data for the latest available year for those countries for which 2014 data were missing: Bulgaria
(2010), Greece (2013), Ukraine (2012) and Russia (2013).
Northern Europe: Denmark, Finland, Iceland, Norway, Sweden.
Western Europe: Austria, Belgium, Germany, France, Ireland, Luxembourg, Netherlands, Switzerland, the UK.
Southern Europe: Greece, Italy, Portugal, Spain.
Central Europe: Bulgaria, Czech Republic, Hungary, Poland, Slovakia, Slovenia.
Eastern Europe: Belarus, Estonia, Latvia, Lithuania, Ukraine, Russia.
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Discussion
The combined impact of smoking, obesity and alcohol on
e0 declined among men from 6.6 years in 1990 to 5.8 years
in 2014, mainly due to declining smoking-attributable
mortality. Among women, the combined impact increased
from 1.9 to 2.3 years due to mortality increases in all three
lifestyle-related factors. The observed increase in e0 over
the 1990–2014 period was 5.0 years for men and 4.0 years
for women. Without the combined effect of these three fac-
tors, the increase in e0 would have been 4.2–4.3 years for
both men and women, and would have been more similar
between countries for men.
To estimate mortality attributable to smoking, obesity
and alcohol combined, we multiplicatively aggregated the
risk-factor-specific mortality fractions, assuming that the
risk factors are independent and uncorrelated.45 In case the
effects of these three lifestyle risk factors were to overlap,
rather than having synergistic relations, their joint contri-
bution would be overestimated. It is unknown how the
above-mentioned bias is changing over time and conse-
quently how this would affect our results on the combined
impact of the three lifestyle factors on trends in life
expectancy.
The techniques employed to estimate smoking-, obesity-
and alcohol-attributable mortality were selected based on
a careful assessment of different estimation techniques48–50
and data availability. However, these techniques provide
estimates only and should be interpreted as such.
Comparing our estimates of the PGLE from the elimina-
tion of smoking-, obesity- and alcohol-attributable
Figure 2 Trends over time in the potential gain in life expectancy (PGLE) after eliminating smoking-, obesity- and alcohol-attributable mortality (sepa-
rately and combined), 1990–2014*, by European region and sex. Lifestyle-attributable mortality refers to mortality that is attributable to smoking, obe-
sity and alcohol combined. *For 2011 up to 2014, the weighted averages were calculated using the data for the latest available year: Bulgaria (2010),
Greece (2013), Ukraine (2012) and Russia (2013).
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mortality with those using the Global Burden of Diseases
2017 data44 revealed that our estimates in 2014 for men
were, on average, 0.3 years lower for obesity in Eastern
Europe and for alcohol across all regions, but 0.7 years
higher for smoking in CEE; for women, they were, on aver-
age, largely similar for alcohol, but 0.3–0.4 years lower for
obesity in CEE and for smoking in Southern and Eastern
Europe (see Supplementary Table 3, available as
Supplementary data at IJE online). Based on this compari-
son, our estimates seem generally conservative.
The differences in the impact of lifestyle on trends in e0
between men (accelerating the increase) and women (decel-
erating the increase) are mainly attributable to large sex
differences in the onset of the smoking epidemic. Because
men generally started smoking in large numbers 20–
30 years earlier than women did, trends in smoking-
attributable mortality had been declining for several deca-
des for men, but were still increasing for women in most
countries.15,16 This earlier onset of smoking among men
can be attributed to the earlier uptake of risky health
behaviours by men than by women.51 However, women’s
behaviours followed those of men when their roles in soci-
ety changed due to women’s emancipation and rising fe-
male labour-force participation.52 The more recent trends
in obesity- and alcohol-attributable mortality have been
largely similar for men and women, in line with their rela-
tively similar prevalence trends.42,53
The observed differences between regions and countries
in the impact of lifestyle factors on trends in e0 can also be
linked to international differences in the progression of the
smoking epidemic. For example, the large impact of life-
style factors on trends among Central European women
can be attributed to the later start and the greater impact
of the smoking epidemic.16 Large international differences
in alcohol-prevalence trends, however, have also played a
role. Among men, the high levels and increasing trends in
alcohol prevalence until around 2005 in Eastern
Europe37 led to a deceleration, instead of an acceleration,
of life-expectancy increases. In contrast, among women
in Southern Europe, declines in alcohol prevalence54
contributed to the relatively small negative impact of life-
style on life-expectancy trends. These differences can be
mainly attributed to differences in drinking cultures (spi-
rits in Eastern Europe, wine in Southern Europe) and
in economic development (economic hardship in Eastern
Europe).20
We observed that the e0 trends for non-lifestyle-
attributable mortality ran parallel for men and women,
and were more similar between countries than the ob-
served e0 trends for men. Moreover, from a longer-term
perspective, the e0 trends after excluding lifestyle-
attributable mortality seem relatively stable over time
(Supplementary Figure 3, available as Supplementary data
at IJE online). This generally uniform trend may capture
the underlying gradual long-term increase in life expec-
tancy in Europe, which, as postulated in the epidemiologi-
cal transition theory,55 reflects the long-term effects of
socio-economic growth and medical progress. In European
countries, large increases in gross domestic product per
capita since the late nineteenth century56 drove the secular-
Table 2 Impact of smoking, obesity and alcohol (separately and combined) on the change in life expectancy at birth (e0) in 30
European countries from 1990 until 2014a by sex and region
Change in e0 1990–2014
a (in years)
Observed Without smoking Without obesity Without alcohol Without smoking, obesity and alcohol
Men
Europe 4.98 3.48 5.54 5.29 4.24
Northern Europe 6.31 4.89 6.69 6.30 5.29
Western Europe 6.51 4.72 6.96 6.20 4.93
Southern Europe 6.59 5.22 6.96 5.94 5.09
Central Europe 7.52 5.51 8.04 7.54 6.06
Eastern Europe 1.20 –0.10 1.85 2.42 1.56
Women
Europe 3.96 4.10 4.15 4.03 4.32
Northern Europe 4.34 4.77 4.50 4.33 4.89
Western Europe 4.66 5.07 4.87 4.55 5.10
Southern Europe 5.03 5.28 5.16 4.78 5.14
Central Europe 6.01 6.68 6.11 6.03 6.71
Eastern Europe 1.87 1.63 2.04 2.24 2.14
aFor countries for which 2014 data were missing, we used data up until the latest available year: Bulgaria (2010), Greece (2013), Ukraine (2012) and Russia
(2013).
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mortality decline during the twentieth century. From the
1950s onwards, increases in life expectancy were achieved
primarily through declines in adult cardiovascular mortal-
ity linked to medical improvements (hypertension treat-
ments, statins, thrombolysis, stents).57
Although country differences in e0 trends can be largely
explained by the three lifestyle factors studied, important
country differences in e0 for non-lifestyle-attributable
mortality remain. Particularly notable are the less favour-
able trends in Eastern Europe (i.e. former Soviet republics).
The declines in e0 in the early 1990s may be attributable to
the economic and political disruptions that followed the
dissolution of the Soviet Union.21,58,59 However, from
2000 onwards, the e0 trends without lifestyle-attributable
mortality were again more similar between countries. This
convergence might reflect increasing similarities between
Figure 3 Trends in life expectancy at birth (e0), observed (¼ all-cause mortality) versus after excluding lifestyle-attributable mortality (¼ non-lifestyle-
attributable mortality), 1990–2014*, by European region and sex. Lifestyle-attributable mortality refers to mortality that is attributable to smoking,
obesity and alcohol combined. *For 2011 up to 2014, the weighted averages were calculated using the data for the latest available year: Bulgaria
(2010), Greece (2013), Ukraine (2012) and Russia (2013).
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countries in factors such as healthcare seeking, health-
related policies and socio-cultural trends.
Smoking, obesity and alcohol likely contribute not
only to country differences in e0 trends, but also to
socio-economic differences in e0 trends. The three life-
style factors contribute substantially to socio-economic dif-
ferences in mortality60 due to higher current prevalence and
associated mortality among people with low than with high
SES.61 This contribution has increased over time, due to
socio-economic differences in the uptake of new behaviours,
and those with a higher socio-economic position generally
being the first to change to healthier behaviours
again.15,62,63
Because lifestyle factors have a large effect on life-
expectancy trends, it is important to consider them when
studying the stagnation in the increase in life expectancy.
In Europe—particularly in the UK, but also in France,
Germany, Sweden and the Netherlands—slowdowns in
life-expectancy increases have been observed since
2011.24,25 Increases in both obesity prevalence25 and alco-
hol abuse among UK adults24 have been mentioned as po-
tential causes. For women in France, Germany, Sweden
and the Netherlands, rapid increases in smoking-
attributable mortality (Supplementary Figure 1b, available
as Supplementary data at IJE online)16 are likely contribu-
tors as well. Decomposing recent mortality trends into
lifestyle-attributable mortality and remaining mortality
may help to explain recent e0 trends.
Similarly, when predicting future trends in life expec-
tancy, the time-varying impact of lifestyle factors should
be considered. Because mortality forecasts mostly rely on
the extrapolation of past age-specific mortality trends,64
a major challenge is to identify an underlying mortality
trend that is sufficiently stable to serve as the basis for ex-
trapolation.65,66 At the same time, such extrapolation
should not ignore the factors that may cause deviations
from this underlying trend.41,65,66 Our results indicate,
first, that the past trends in non-lifestyle-attributable
mortality serve as a better baseline for extrapolations
than all-cause mortality; and, second, that smoking, obe-
sity and alcohol are factors that seem to cause important
deviations that should be predicted separately using more
advanced techniques. Indeed, over the short term, less
favourable e0 trends are expected because continued
increases in smoking-attributable mortality for women in
most countries and general increases in obesity-
attributable mortality are anticipated. Increases in e0 are
expected to become more favourable again once the
declines in smoking-attributable mortality among women
become more widespread and the hypothesized decline in
obesity-attributable mortality17,18,28 eventually sets in.
Supplementary data
Supplementary data are available at IJE online.
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